|
1
|
Balistreri CR, Caruso C and Candore G: The
role of adipose tissue and adipokines in obesity-related
inflammatory diseases. Mediators Inflamm. 2010:8020782010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mårin P, Andersson B, Ottosson M, et al:
The morphology and metabolism of intraabdominal adipose tissue in
men. Metabolism. 41:1242–1248. 1992.PubMed/NCBI
|
|
3
|
Wajchenberg BL: Subcutaneous and visceral
adipose tissue: their relation to the metabolic syndrome. Endocr
Rev. 21:697–738. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pascot A, Lemieux S, Lemieux I, et al:
Age-related increase in visceral adipose tissue and body fat and
the metabolic risk profile of premenopausal women. Diabetes Care.
22:1471–1478. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sharma AM and Staels B: Review: Peroxisome
proliferator-activated receptor gamma and adipose tissue -
understanding obesity-related changes in regulation of lipid and
glucose metabolism. J Clin Endocrinol Metab. 92:386–395. 2007.
View Article : Google Scholar
|
|
6
|
Fusco R, Galgani M, Procaccini C, et al:
Cellular and molecular crosstalk between leptin receptor and
estrogen receptor-{alpha} in breast cancer: molecular basis for a
novel therapeutic setting. Endocr Relat Cancer. 17:373–382. 2010.
View Article : Google Scholar
|
|
7
|
Hlavna M, Kohut L, Lipkova J, et al:
Relationship of resistin levels with endometrial cancer risk.
Neoplasma. 58:124–128. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Masaki T and Yoshimatsu H: Obesity,
adipokines and cancer. Transl Oncogenomics. 3:45–52. 2008.
|
|
9
|
Nyante SJ, Gammon MD, Kaufman JS, et al:
Common genetic variation in adiponectin, leptin, and leptin
receptor and association with breast cancer subtypes. Breast Cancer
Res Treat. 129:593–606. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SH, Nagalingam A, Saxena NK, Singh SV
and Sharma D: Benzyl isothiocyanate inhibits oncogenic actions of
leptin in human breast cancer cells by suppressing activation of
signal transducer and activator of transcription 3. Carcinogenesis.
32:359–367. 2011. View Article : Google Scholar
|
|
11
|
Carter JC and Church FC: Obesity and
breast cancer: the roles of peroxisome proliferator-activated
receptor-γ and plasminogen activator inhibitor-1. PPAR Res.
2009:3453202009.
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
13
|
Priego T, Sánchez J, Picó C and Palou A:
Sex-differential expression of metabolism-related genes in response
to a high-fat diet. Obesity (Silver Spring). 16:819–826. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nomaguchi K, Tanaka M, Misawa E, et al:
Aloe vera phytosterols act as ligands for PPAR and improve the
expression levels of PPAR target genes in the livers of mice with
diet-induced obesity. Obes Res Clin Pract. 5:e169–e266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kavanagh K, Jones KL, Sawyer J, et al:
Trans fat diet induces abdominal obesity and changes in insulin
sensitivity in monkeys. Obesity (Silver Spring). 15:1675–1684.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hamdy O, Porramatikul S and Al-Ozairi E:
Metabolic obesity: the paradox between visceral and subcutaneous
fat. Curr Diabetes Rev. 2:367–373. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duffield JA, Vuocolo T, Tellam R, et al:
Intrauterine growth restriction and the sex specific programming of
leptin and peroxisome proliferator-activated receptor gamma
(PPARgamma) mRNA expression in visceral fat in the lamb. Pediatr
Res. 66:59–65. 2009. View Article : Google Scholar
|
|
18
|
Dewulf EM, Cani PD, Neyrinck AM, et al:
Inulin-type fructans with prebiotic properties counteract GPR43
overexpression and PPARgamma-related adipogenesis in the white
adipose tissue of high-fat diet-fed mice. J Nutr Biochem.
22:712–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arai K, Soga T, Ohata H, Otagiri A and
Shibasaki T: Effects of food restriction on peroxisome
proliferator-activated receptor-gamma and glucocorticoid receptor
signaling in adipose tissues of normal rats. Metabolism. 53:28–36.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barak Y and Kim S: Genetic manipulations
of PPARs: effects on obesity and metabolic disease. PPAR Res.
2007:127812007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nicholas SB, Kawano Y, Wakino S, Collins
AR and Hsueh WA: Expression and function of peroxisome
proliferator-activated receptor-gamma in mesangial cells.
Hypertension. 37:722–727. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Larsen TM, Toubro S and Astrup A:
PPARgamma agonists in the treatment of type II diabetes: is
increased fatness commensurate with long-term efficacy? Int J Obes
Relat Metab Disord. 27:147–161. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lehrke M and Lazar MA: The many faces of
PPARgamma. Cell. 123:993–999. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Frühbeck G and Salvador J: Role of
adipocytokines in metabolism and disease. Nutr Res. 24:803–826.
2004.
|
|
25
|
Tontonoz P and Spiegelman BM: Fat and
beyond: the diverse biology of PPARgamma. Annu Rev Biochem.
77:289–312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Malavazos AE, Cereda E, Morricone L, et
al: Monocyte chemoattractant protein 1: a possible link between
visceral adipose tissue-associated inflammation and subclinical
echocardiographic abnormalities in uncomplicated obesity. Eur J
Endocrinol. 153:871–877. 2005. View Article : Google Scholar
|
|
27
|
Huber J, Kiefer FW, Zeyda M, et al: CC
chemokine and CC chemokine receptor profiles in visceral and
subcutaneous adipose tissue are altered in human obesity. J Clin
Endocrinol Metab. 93:3215–3221. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen A, Mumick S, Zhang C, et al: Diet
induction of monocyte chemoattractant protein-1 and its impact on
obesity. Obes Res. 13:1311–1320. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park HS, Park JY and Yu R: Relationship of
obesity and visceral adiposity with serum concentrations of CRP,
TNF-alpha and IL-6. Diabetes Res Clin Pract. 69:29–35. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Monti P, Leone BE, Marchesi F, et al: The
CC chemokine MCP-1/CCL2 in pancreatic cancer progression:
regulation of expression and potential mechanisms of antimalignant
activity. Cancer Res. 63:7451–7461. 2003.PubMed/NCBI
|
|
31
|
Ueno T, Toi M, et al: Significance of
macrophage chemoattractant protein-1 in macrophage recruitment,
angiogenesis, and survival in human breast cancer. Clin Cancer Res.
6:3282–3289. 2000.PubMed/NCBI
|
|
32
|
Saji H, Koike M, Yamori T, et al:
Significant correlation of monocyte chemoattractant protein-1
expression with neovascularization and progression of breast
carcinoma. Cancer. 92:1085–1091. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ohta M, Kitadai Y, Tanaka S, et al:
Monocyte chemoattractant protein-1 expression correlates with
macrophage infiltration and tumor vascularity in human gastric
carcinomas. Int J Oncol. 22:773–778. 2003.
|
